Literature DB >> 9568701

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

C Ferri1, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi, A Santucci.   

Abstract

Circulating soluble E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular adhesion molecule-1 (VCAM-1) concentrations were evaluated in 93 nonobese essential hypertensive patients, of whom 16 had impaired glucose tolerance and hyperlipidemia (group I); 25 had impaired glucose tolerance (group II); 28 had hyperlipidemia (group III); and 24 had no metabolic abnormalities (group IV). A group of 22 healthy volunteers served as a control group. All groups were without clinical or ultrasound evidence of vascular lesion and were matched for age, sex, and BMI. Endothelial soluble adhesion molecules were measured at baseline, during an oral glucose tolerance test, and after 12 weeks of either enalapril or placebo treatments. Plasma soluble E-selectin, ICAM-1, and VCAM-1 were higher (P < 0.05) in group I and II than in the other groups (group I: E-selectin, 96.1+/-27.1; ICAM-1, 304.0+/-102.1; VCAM-1, 626.1+/-156.2 microg/l. Group II: E-selectin, 88.0+/-18.0; ICAM-1, 268.0+/-84.1; VCAM-1, 594.1+/-140.9 microg/I. Group III: E-selectin, 70.1+/-18.1; ICAM-1, 195.1+/-68.0; VCAM-1, 495.9+/-110.1 microg/l. Group IV: E-selectin, 65.1+/-16.1; ICAM-1, 168.1+/-64.0; VCAM-1, 472.1+/-108.2 microg/l). Soluble adhesins levels were not higher than normal in groups III and IV. Plasma soluble ICAM-1 concentrations increased in group I after glucose administration and were directly correlated with 2-h insulin levels (r=0.648, P=0.007). Compared with placebo, 12 weeks of enalapril treatment significantly (P < 0.0001) reduced soluble E-selectin, ICAM-1, and VCAM-1. Decrements of soluble adhesins were not dependent on enalapril-related blood pressure changes. Therefore, an early endothelial activation was present in essential hypertensive patients with impaired glucose tolerance, regardless of the presence of hyperlipidemia. ACE inhibition counteracted such endothelial activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568701     DOI: 10.2337/diabetes.47.4.660

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 3.  Adiponectin resistance and vascular dysfunction in the hyperlipidemic state.

Authors:  Rong Li; Wayne Bond Lau; Xin Liang Ma
Journal:  Acta Pharmacol Sin       Date:  2010-08-30       Impact factor: 6.150

Review 4.  Cardiovascular complications of obesity in adolescents.

Authors:  F Orio; S Palomba; T Cascella; S Savastano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

5.  RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.

Authors:  Christopher Chuong; Joseph Katz; Kaleb M Pauley; Marievic Bulosan; Seunghee Cha
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

6.  Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Yayoi Kurita-Nakamura; Takanori Matsui; Takafumi Yoshida; Tsutomu Imaizumi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

7.  Circulating levels of cell adhesion molecules in hypertension.

Authors:  Kavita K Shalia; Manoj R Mashru; Jagdish B Vasvani; Rajashree A Mokal; Shilpa M Mithbawkar; Priti K Thakur
Journal:  Indian J Clin Biochem       Date:  2009-12-30

Review 8.  Endothelial function and the prediction of CVD in diabetes.

Authors:  Raffaelle Bugiardini
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

9.  Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity.

Authors:  Benton Maglinger; Madison Sands; Jacqueline A Frank; Christopher J McLouth; Amanda L Trout; Jill M Roberts; Stephen Grupke; Jadwiga Turchan-Cholewo; Ann M Stowe; Justin F Fraser; Keith R Pennypacker
Journal:  J Neuroinflammation       Date:  2021-05-11       Impact factor: 8.322

10.  s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal.

Authors:  Diana Rubin; Sandra Claas; Maria Pfeuffer; Michael Nothnagel; Ulrich R Foelsch; Juergen Schrezenmeir
Journal:  Lipids Health Dis       Date:  2008-09-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.